Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML Menin Inhibitor Research

Courtney DiNardo

MD, MSCE

🏢MD Anderson Cancer Center🌐USA

Professor, Department of Leukemia

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Courtney DiNardo is a leading leukemia investigator who pioneered venetoclax-based combinations that transformed AML treatment. She has extended her work to evaluate menin inhibitors in combination with venetoclax and hypomethylating agents, establishing rational combination strategies. Her clinical trials have established new standards of care for older and unfit AML patients.

Share:

🧪Research Fields 研究领域

Venetoclax AML
IDH-mutant leukemia
Menin inhibitor combinations
AML targeted therapy
Clinical trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Courtney DiNardo 的研究动态

Follow Courtney DiNardo's research updates

留下邮箱,当我们发布与 Courtney DiNardo(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment